Original Research
Published on 04 Jul 2024
Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis
in Thoracic Oncology
- 969 views